Healix

News & Events

Filter
All Categories
News
Events

Video Highlight: Healix Pharmacy Services

Learn more about our accredited pharmacy that offers a wide range of patient-specific injectable and infusion medication nationwide 

Read More

Infectious Diseases Society of America Honors 219 Distinguished Physicians, Scientists

Lucinda J. Van Anglen, B.S., Pharm.D., of Healix Infusion Therapy has been named a Fellow by the Infectious Diseases Society of America.

Read More

Meet Healix at IDWeek 2023

Visit our team while attending the premier infectious disease conference in Boston, MA

Read More

High Adherence and Cost Savings with Home OPAT Provided Through Infectious Disease Physician Office Infusion Centers

A multicenter, retrospective study evaluated adherence to therapy and POIC visits along with cost savings associated with therapy de-escalation in patients receiving self-administered OPAT through POICs.

Read More

Healix is proud to exhibit at the NORM 2022 Annual Conference in Atlanta, GA

Visit Healix Booth #T7 to learn more about our services

Read More

Transition to Subcutaneous Immune Globulin 16.5% Improves Patient-Reported Quality of Life

The study was presented at the AAAAI 2022 Annual Meeting and was the first real-world patient-reported QOL survey in patients receiving IGSC 16.5%.

Read More

Visit Healix Booth #25 at the Texas Neurological Society Summer Conference

Chat with a Healix Representative at the TNS Summer Conference to learn about how we deliver Patient & Physician Peace of Mind

Read More

Healix is an exhibitor at the 2022 NLA Scientific Sessions

Speak with the Healix Team while attending the NLA Scientific Sessions and discover our premier infusion management services for cardiology providers.

Read More

Healix is excited to support the GSR Annual Meeting

Join Healix at GSR to learn about our leading infusion management solutions for Rheumatology providers.

Read More

Healix is a proud exhibitor sponsor of CCR-East

Visit the Healix booth to learn about our industry-leading infusion management expertise for rheumatology practices.

Read More

A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)

A study evaluated the distribution and resistance patterns of the Gram-negative pathogens (GNP) isolated from genitourinary patients treated in POICs over a 3-year period.

Read More

The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)

The coronavirus disease 2019 (COVID-19) pandemic dramatically affected the provision of healthcare in the U.S. with sharp declines in routine and elective healthcare services. A study evaluated how COVID-19 impacted the provision of OPAT in 14 POICs nationwide.

Read More

Meet with Healix at AAAAI in Booth #1443

Healix is proud to participate in the 2022 AAAAI Annual Meeting in Phoenix.

Read More

Come Visit the Healix Team at STAR

Visit Healix at the STAR 2022 Annual Meeting to learn more about our office-based infusion services for rheumatology practices.

Read More

Meet the Healix Team at ACAAI

Stop by booth #746 to learn about how we help practices like yours provide a full continuum of care for your patients.

Read More

Healix Collaborative Research at ACG 2021

Healix is proud to participate in collaborative research with our clients at the 2021 American College of Gastroenterology (ACG) Annual Meeting.

Read More

Healix Collaborative Research at IgNS

Healix is excited to once again present our collaborative Research at IgNS National Conference 2021.

Read More

NORM 2021 Annual Meeting

Stop by our booth at the NORM Annual Meeting to learn about our office-based infusion services for your Rheumatology practice.

Read More

IDWeek 2021

Visit Healix at IDWeek 2021, Sept. 29 – Oct. 3, to learn why Healix is the premier provider of outpatient infusion management services.

Read More

2021 Annual Meeting of the Florida Society of Neurology

Healix is excited to participate at the 2021 Annual Meeting of the Florida Society of Neurology, September 24-26, 2021, in Orlando, Florida.

Read More

COVID-19 Pandemic Initial Impact on Outpatient Intravenous Antibiotic Therapy

An analysis of the initial impact of the COVID-19 pandemic on the rate of hospital patient referrals for outpatient antimicrobial therapy

Read More

COVID-19 pandemic impact on infusion utilization

Physician office infusion centers deliver lower cost and higher adherence — even during a pandemic.

Read More

Happy National Pharmacy Week (October 18-24) from Healix!

In celebration of Pharmacy Week 2020, the entire team at Healix would like to sincerely thank all pharmacists, pharmacy technicians, and pharmacy personnel for their service and dedication to the pharmacy profession. 

Read More

Healix Research at the American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting

Healix is proud to participate in clinical research at the American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting November 12-16, 2020

Read More

Healix Collaborative Research with the GI Alliance at the American College of Gastroenterology (ACG) Annual Meeting 2020

Healix is a proud participant of collaborative research with the GI Alliance at the 2020 American College of Gastroenterology (ACG) Annual Meeting. Visit the poster presentation at this year’s virtual conference October 23 – 28, 2020.

Read More

Join Healix at IDWeek 2020

Visit the Healix virtual booth at IDWeek October 22 – 24, 2020 to learn how we can help infectious disease practices like yours to provide unparalleled infusion patient care.

Read More

Healix Research at the Immunoglobulin National Society (IgNS) 9th National Conference 2020

Healix is excited to present our research data on Cutaquig® at the Immunoglobulin National Society (IgNS) 9th National Conference 2020.

Read More

Healix Demonstrates Hospital Avoidance with Provision of Outpatient Antimicrobial Therapy (OPAT): A Leader in the Field for Over 30 Years

Healix Infusion Therapy, LLC has demonstrated success in achieving hospital avoidance when providing outpatient antimicrobial therapy (OPAT) to patients with serious infections through physician offices.

Read More

Healix Announces First Real-World Study of Immune Globulin Subcutaneous 16.5% (Cutaquig®) Featured in the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Healix Infusion Therapy is pleased to announce that its collaborative research study regarding Immune Globulin Subcutaneous 16.5% (Cutaquig®) is now accessible in the AAAAI Annual Meeting Virtual Poster Hall.

Read More

Happy National Nurses Week (May 6-12) from Healix!

The team at Healix would like to recognize and thank nurses across the nation for their dedication to the nursing profession and the time they sacrifice away from their loved ones to care for those in need.

Read More

Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study

Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in theleading scientific journal, Open Forum Infectious Diseases.

Read More

Thank You Healthcare Heroes!

The team at Healix would like to thank all the healthcare heroes who are on the front lines treating patients during this unprecedented time with the COVID-19 crisis.

Read More

State of Texas Association of Rheumatologists (STAR) Annual Meeting

Meet the Healix team on February 28, at the State of Texas Association of Rheumatologists (STAR) Annual Meeting in Houston, TX.

Read More

Tennessee Rheumatology Society (TRS) Annual Scientific Meeting

Meet the Healix team on January 25, at the Tennessee Rheumatology Society (TRS) Annual Meeting in Franklin, TN.

Read More

Celebrating 30 Years of Excellence

Healix is proud to celebrate over 30 years of infusion excellence.

Read More

American College of Rheumatology (ACR) Annual Meeting

Meet the Healix team on November 10-12, 2019, at the American College of Rheumatology Annual Meeting in Atlanta, GA.

Read More

American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting

Meet the Healix team in Houston, November 7-11, 2019, to learn about how we help practices like yours to provide unparalleled infusion patient care. 

Read More

American College of Gastroenterology (ACG) Annual Meeting

Join Healix at the 2019 American College of Gastroenterology (ACG) Annual Meeting October 25-28, 2019.

Read More

CHEST Annual Meeting

Our team is excited to attend the 2019 CHEST conference in New Orleans, LA, October 21-23, 2019.

Read More

IDWeek

Visit our team at IDWeek October 2 – 6, 2019, in Washington D.C. to learn how we can help infectious disease practices like yours to provide unparalleled infusion patient care.

Read More

Rheumatology Association of Minnesota and Dakotas (RA-MD)

Join Healix in Bloomington, MN on September 28, 2019, for the Rheumatology Association of Minnesota and Dakotas (RA-MD) Annual Meeting.

Read More

Congress of Clinical Rheumatology (CCR) Symposium

Visit the Healix team at the Congress of Clinical Rheumatology (CCR) Symposium on September 26 – 29, 2019 in San Diego, CA.

Read More

Illinois State Neurological Society (ISNS) Annual Meeting

Meet the Healix team September 21, 2019, at the Illinois State Neurological Society (ISNS) Annual Meeting in Chicago, IL.

Read More

Virginia Society of Rheumatologists 32nd Annual Scientific Meeting

Healix will be attending and exhibiting at the 2019 Virginia Society of Rheumatologists 32nd Annual Scientific Meeting on September 20- 22, 2019, in Alexandria, VA.

Read More

12th Annual Perspectives in Rheumatic Diseases Annual Meeting

Join Healix in Las Vegas, NV on September 20 – 21, 2019, for the 12th Annual Perspectives in Rheumatic Diseases Annual Meeting.

Read More

Florida Society of Neurology (FSN) Annual Meeting

Healix is proudly exhibiting at the upcoming Florida Society of Neurology Annual Meeting on September 13 -15, 2019, in Orlando, FL.

Read More

National Organization of Rheumatology Managers (NORM) Annual Meeting

Meet with the Healix team at the National Organization of Rheumatology Managers (NORM) Conference on September 12 – 14, 2019, in Grand Rapids, MI.

Read More

Rheumatology Society of New Mexico (RSNM) Annual Meeting

Healix will be exhibiting at the Rheumatology Society of New Mexico on September 7, 2019, in Albuquerque, NM.

Read More

Missouri Kansas Neurological Society (MKNS) Annual Meeting

Visit with the Healix team at Missouri Kansas Neurological Society Annual Meeting on September 7, 2019, in Branson, MO!

Read More

Long Island Allergy & Asthma Society (LIAAS) Annual Meeting

Join Healix in Montauk, New York, on September 6 – 8, 2019, for the 2019 Long Island Allergy & Asthma Society (LIAAS) Annual Meeting.

Read More

Ohio Association of Rheumatology (OAR) Annual Meeting

Healix is excited to exhibit at the upcoming Ohio Association of Rheumatology Annual Meeting on August 23-24, 2019, in Columbus, OH.

Read More

GI Outlook 2019: The Practice Management Conference

Meet the Healix team August 2-4, at the GI Outlook Conference in Hollywood, CA. Visit booth 21 to discover how working with Healix gives you the advantage!

Read More

Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®

Healix Infusion Therapy is pleased to announce that it has been selected as a limited distribution network partner for Cutaquig by Octapharma AG. Cutaquig, Octapharma’s new subcutaneous immune globulin, launches this week.

Read More

Texas Infectious Diseases Society (TIDS) Annual Meeting

Healix will be attending and exhibiting at the Texas Infectious Diseases Society (TIDS) Annual Meeting on June 7-9., 2019, in Lost Pines, Texas. Come and visit with our team to learn about.

Read More

Arizona United Rheumatology Alliance (AURA) Annual Meeting

Join Healix in sunny Sedona, Arizona, on May 31 – June 2, 2019, for the Arizona United Rheumatology Alliance (AURA) Annual Meeting. Our team would love to meet with you to discuss how.

Read More

Georgia Society of Rheumatology (GSR) Annual Meeting

Healix is proudly exhibiting at the upcoming Georgia Society of Rheumatology (GSR) Annual Meeting on May 31 – June 2, 2019, at the Ritz-Carlton, Reynols Plantation, in Greensboro, Georgia. If you are.

Read More

Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting

Are you attending the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting on May 28 – June 1 in Seattle, Washington? Come visit the Healix booth to discuss our expert infusion management.

Read More

Digestive Disease Week (DDW)

Come and visit with the Healix team at Digestive Disease Week (DDW) on May 19-21, 2019, in San Diego! We would love to meet with you to discuss how a Healix-managed.

Read More

American Academy of Neurology (AAN) Annual Meeting

Join Healix at the 2019 American Academy of Neurology (AAN) Annual Meeting on May 4-8, 2019, in Philadelphia, Pennsylvania. Our team of Healix representatives will be available at our booth.

Read More

Healix Selects Citus Health to Digitally Transform Communication Streams and Care Coordination

Healix, the nation’s leader in providing physician office-based infusion services, will implement the Citus Health digital solution suite to streamline multi-office healthcare communications and automate documentation workflows to provide.

Read More

Healix Announces Strategic Partnership with WeInfuse

SUGAR LAND, TX (December 6, 2018) – Healix, the nation’s leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow.

Read More

Healix Announces Strategic Partnership with DoseMe for Precision Dosing

SUGAR LAND, TX (July 20, 2018) – Healix, the nation’s leader in physician office based infusion services, announced a strategic relationship with DoseMe, a precision dosing decision support platform specifically.

Read More

TA Associates Announces Investment in Healix

BOSTON and SUGAR LAND, Texas, December 18, 2017 – TA Associates, a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Healix, a provider of outsourced.

Read More

Healix Relocates to New State-of-the-Art Pharmacy Facility in Sugar Land, Texas

SUGAR LAND, TX (July 28, 2017) – Healix Infusion Therapy, Inc. is proud to announce the relocation of its pharmacy operation to a new, state-of-the-art facility in Sugar Land, Texas. With more than 28.

Read More

Healix is Now a National Provider of Trogarzo™ (ibalizumab-uiyk)

SUGAR LAND, TX (July 28, 2017) – Healix® is Now a National Provider of Trogarzo™ (ibalizumab-uiyk). Trogarzo™ is a new humanized monoclonal antibody for the treatment of multidrug-resistant (MDR) HIV-1.

Read More

Outpatient Treatment of Osteomyelitis with Telavancin

SUGAR LAND, TX (July 14, 2017) – Gram-positive osteomyelitis was successfully treated with telavancin, as published in an article in The International Journal of Antimicrobial Agents.

Read More

Healix® is Now a National Provider of Cuvitru® [Immune Globulin Subcutaneous (Human)] 20%

SUGAR LAND, TX (March 20, 2017) – Healix has been selected among an exclusive number of distributers to become a national provider of Cuvitru [Immune Globulin Subcutaneous (Human)] 20%. Immunologists who partner with Healix.

Read More

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers

SUGAR LAND, TX (May 23, 2016) – Dalbavancin is a long-acting lipoglycopeptide, approved for the treatment of acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria. A retrospective study was.

Read More

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a POIC

SUGAR LAND, TX (January 25, 2016) – Pediatric outpatient antimicrobial therapy (OPAT) is increasing, however, data on management, safety, and clinical outcomes are limited. A two-year retrospective, observational study was conducted of 64 pediatric.

Read More

A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia OPAT in a POIC

SAN DIEGO, CA (October 10, 2015) – Septicemia constitutes a major cause for 30-day hospital readmissions and is the most expensive condition treated in U.S. hospitals according to the Agency for Healthcare.

Read More

Low Hospital Admission Rates Following POIC-Based Outpatient Treatment with Intravenous Antibiotics

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) provided by a physician office infusion center revealed an overall low 30-day hospital admission rate of 6.8% compared to 26% previously reported. This collaborative, retrospective study.

Read More

Comparison of Outpatient Antimicrobial Therapy (OPAT) in a POIC vs. Traditional Home Health Care

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) in a physician office infusion center showed improved quality of care in contrast to a traditional home health care setting. A collaborative, retrospective study.

Read More

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections with Ertapenem

SAN FRANCISCO, CA (October 4, 2013) – A retrospective database review was conducted of patients aged 18 and older receiving ertapenem therapy for UTI between July 1, 2010, and December 31, 2013. Seventy-five patients with a UTI diagnosis.

Read More

Clinical & Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy among Indigent Patients

SAN FRANCISCO, CA (October 4, 2013) – This study is a report of clinical and economic outcome data of a hospital-funded Indigent Healthcare Program conducted in 11 Infectious Disease (ID) Physician Office Infusion Centers (POICs).

Read More

Outpatient Parenteral Antimicrobial Therapy for Treatment of Complicated Intra-Abdominal Infections

SAN FRANCISCO, CA (October 4, 2013) – A multi-center retrospective review of 120 patients receiving intravenous antibiotics (IVAB) for complicated intra-abdominal infections (IAI) in a physician office infusion center (POIC) was conducted to determine the.

Read More

Outpatient Parenteral Antimicrobial Therapy for Treatment of Complicated Intra-Abdominal Infections

SAN FRANCISCO, CA (October 9, 2013) – A multi-center review of 100 patients receiving Vancomycin was conducted to determine the effectiveness of patient monitoring and the recognition of adverse events in an outpatient setting.

Read More

Successful Treatment of Polymicrobial Calcaneal Osteomyelitis

SUGAR LAND, TX – Multidrug-resistant osteomyelitis was successfully treated with telavancin, rifampin, and meropenem, as published in an article in The Annals of Pharmacotherapy. Primary author was Mary Beth Brinkman.

Read More

C. difficile-Associated Diarrhea Incidence & Outcomes in Physician Office Infusion Centers

SAN DIEGO, CA (October 19, 2012) – A retrospective review of 1,352 patients treated at nine Infectious Disease POICs with intravenous antibiotics (IVAB) from January 1 to June 30, 2011, was conducted to assess the reduced risk level.

Read More

Cost & Outcomes Comparison of Patients Whose Treatment Began in Infusion Center vs. After Discharge

SAN DIEGO, CA (October 19, 2012) – A retrospective, multicenter review was conducted of eligible patients treated in the POIC from January 1- June 30, 2011, including 30-day follow-up to compare outcomes and costs in.

Read More

Outcomes Comparison of IV Antimicrobials in an Office Infusion Center vs. Home Care Services

SAN DIEGO, CA (October 19, 2012) – A retrospective review was conducted of randomly selected records for patients treated in four Infectious Disease POICs from January 2010-December 2011, to compare patient management and outcomes in.

Read More

Utilization of IV Antimicrobials Over a One-Year Period in Physician Office Infusion Centers

SAN DIEGO, CA (October 19, 2012) – A multi-center retrospective review of 11,616 patients receiving intravenous antimicrobials (IVAM) was conducted to determine utilization of IVAM in POICs and efficient device utilization. In the 65 participating.

Read More

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy Following Hospital Discharge

SAN DIEGO, CA (October 19, 2012) – A retrospective pilot study was conducted of all patients, from January 2011 through April 2012, receiving OPAT under an indigent healthcare program (a hospital-funded program providing IV antibiotics through.

Read More

Low Rates of C. difficile Associated Diarrhea in Patients Receiving IVAB in the Outpatient Setting

BOSTON, MA (October 21, 2011) – Patients receiving intravenous antibiotics in seven Infectious Disease Physician Office Infusion Centers (POICs) experienced a low rate of Clostridium difficile associated diarrhea (2.5 per 10,000 patient days). Of the 934.

Read More

Low Readmission and Recurrence Rates of Bacteremia, Endocarditis & Osteomyelitis in Infusion Centers

BOSTON, MA (October 21, 2011) – A multi-center retrospective review of 203 patients treated with long term intravenous antibiotic therapy in physician office infusion centers (POICs) is effective with clinical success rates of 93% in bacteremia, 88%.

Read More

Treatment with IV Antibiotics in an Outpatient POIC Shows Successful Outcomes and Cost Savings

BOSTON, MA (October 21, 2011) – A 3-year trend analysis was conducted of patients initiated on intravenous antibiotics (IVAB) in an Infectious Disease Physician Office Infusion Center (POIC) during the years 2008 – 2010 for.

Read More

Telavancin Treatment in the Outpatient Setting is Effective

BOSTON, MA (October 21, 2011) – In a 16 month period, 47 patients were treated with telavancin in 15 physician office infusion centers (POICs) with indications for acute bacterial skin and skin structure infections (24), osteomyelitis (19), sepsis (3).

Read More

Healix Launches New App to Boost Client Efficiency

SUGAR LAND, TX (January 1, 2011) – Healix announced the official launch of the iPhone® compatible Healix App, a tool for on-the-go physicians to track formulary options with payer reimbursement data.

Read More

How can we help you?

Get in touch with us or explore our offerings.

"Establishing a relationship with Healix has allowed us to provide our patients with outstanding care while being able to control the clinical situation and achieve the best possible outcomes."

Andrew Krinsky, MD

Infectious Diseases Associates, Sarasota, Florida

Healix Testimonials
2019-04-10T09:58:14-05:00
Andrew Krinsky, MD

Infectious Diseases Associates, Sarasota, Florida

"Establishing a relationship with Healix has allowed us to provide our patients with outstanding care while being able to control the clinical situation and achieve the best possible outcomes."
“The Healix team has set the bar for professionalism, knowledge of the industry, and customer service that other companies typically fail to meet. Healix has made it a fun, effortless, and significant clinical enhancement for our patients!”

Pam Hamby

Infusion Program Director, The Allergy, Asthma, and Sinus Center Offices in Tennessee, Kentucky, & Georgia

Healix Testimonials
2019-04-11T08:12:34-05:00
Pam Hamby

Infusion Program Director, The Allergy, Asthma, and Sinus Center Offices in Tennessee, Kentucky, & Georgia

“The Healix team has set the bar for professionalism, knowledge of the industry, and customer service that other companies typically fail to meet. Healix has made it a fun, effortless, and significant clinical enhancement for our patients!”
“Our practice has now partnered with Healix for over 15 years to provide in-office infusion services to our patients. Healix had made this process seamless and efficient, resulting in outstanding patient care and many satisfied patients. Their nurses and support staff are well trained and professional and a pleasure to work with. It has added a valuable service line to our practice.”

Timothy Ritter, MD

Texas Digestive Disease Consultants, Dallas, Texas

Healix Testimonials
2019-04-11T08:13:15-05:00
Timothy Ritter, MD

Texas Digestive Disease Consultants, Dallas, Texas

“Our practice has now partnered with Healix for over 15 years to provide in-office infusion services to our patients. Healix had made this process seamless and efficient, resulting in outstanding patient care and many satisfied patients. Their nurses and support staff are well trained and professional and a pleasure to work with. It has added a valuable service line to our practice.”
“The Healix infusion business model works. Our collaborative team of physicians, an infusion nurse, and a clinical pharmacy hotline allows for real-time feedback and course correction if necessary. Healix has turned this small clinic into a real service for the community.”

Philip Blum, MD

MHS Physicians of Texas, Houston, Texas

Healix Testimonials
2019-04-11T08:13:50-05:00
Philip Blum, MD

MHS Physicians of Texas, Houston, Texas

“The Healix infusion business model works. Our collaborative team of physicians, an infusion nurse, and a clinical pharmacy hotline allows for real-time feedback and course correction if necessary. Healix has turned this small clinic into a real service for the community.”
0
0
Healix Testimonials
FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound